A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Incyte Corporation
Related studies linked through entity extraction aliases.
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Ruxolitinib in Seborrheic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)
- Status
- COMPLETED
- Phase
- PHASE3
Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo
- Status
- COMPLETED
- Phase
- PHASE2
Neoantigen-based Personalized DNA Vaccine With Retifanlimab PD-1 Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis
- Status
- RECRUITING
- Phase
- PHASE1
The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.
- Status
- TERMINATED
- Phase
- PHASE4
Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors
- Status
- WITHDRAWN
- Phase
- PHASE2
Study to Evaluate of the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa
- Status
- COMPLETED
- Phase
- PHASE2
Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB054707 in Participants With Normal and Impaired Renal Function and Participants on Hemodialysis
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)
- Status
- COMPLETED
- Phase
- PHASE3